ArticleScientific reports2025
Determinants of selective domains of cognitive impairment among diabetes mellitus patients: a primary health care setting-based study in India.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ketogenic metabolic therapy: low-carbohydrate interventions as novel neuroprotective strategies for cognitive dysfunction in diabetes.Frontiers in aging neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive impairment (CI) is a known complication of type II diabetes mellitus (T2DM), potentially hindering effective self-care. While many studies have addressed global cognitive decline, few have explored domain-specific impairments in Indian community settings. This study aimed to assess the extent of CI among T2DM patients and identify the prevalence and determinants of specific deficits in working memory; focused, sustained, divided attention, and problem solving. A primary health care setting-based cross-sectional study was conducted among 441 urban T2DM patients aged 30-65 years in southern India. Participants with ≥ 4 years of diabetes mellitus underwent assessment with the Montreal Cognitive Assessment tool. Those scoring < 26 were assessed using standardized tools for distinct cognitive domains: the Auditory Verbal Learning Test, Color Trail Test, Digit Vigilance Test, Tower of London, and Triads Test. Relevant sociodemographic and clinical variables were collected via a validated interview schedule. The chi-square test, Fisher's exact test, the Mann‒Whitney U test, and binary logistic regression analysis were used to test associations. Of the total 441 participants, 138 (31.3%) had cognitive impairment. Among them, impairments in divided attention, verbal learning, immediate verbal memory, delayed verbal memory, recognition memory, planning and problem-solving ability, sustained attention and processing speed, sustained attention accuracy and impulsivity control, and focused attention and cognitive flexibility were present among 48 (34.7%), 108 (72.8%), 127 (92.0%), 133 (96.3%), 123 (89.1%), 15 (10.8%), 98 (71.0%), 115(83.3%), and 17 (12.3%) patients, respectively. Significant associations were observed between recent random blood sugar levels ≥ 200 mg/dl and impaired verbal learning [adjusted odds ratio (AOR) 2.35 (0.99-5.54), p = 0.052); skilled/unskilled occupation [AOR 9.53 (1.28-71.12), p = 0.028)], homemaker/unemployed occupation [AOR 5.48 (0.96-31.16), p = 0.055], overweight/obese status [AOR 5.05 (1.1-23.08), p = 0.037] and impaired immediate verbal memory; joint family status (p = 0.053), absence of family history of DM [AOR 4.07 (1.87-14.015), p = 0.026] and impaired planning and problem-solving; middle SES and impaired sustained attention (processing speed) [AOR 3.59 (1.35-9.59), p = 0.011]; and being married [AOR 8.4 (1.6-44.5), p = 0.012], absence of family history of DM [AOR 4.38 (1.43-13.4), p = 0.01] and impaired sustained attention (accuracy); and lower SES and impaired focussed attention [AOR 8.96 (1.01-81.85), p = 0.05]. One in three individuals with T2DM had cognitive deficits, particularly in the memory and attention domains. These findings underscore the importance of incorporating domain-specific cognitive screening into routine diabetes care among the high-risk groups identified in this study for early intervention and improved management outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.